speb/financial-data huggingface dataset:
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4749500000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 60499050.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 60499050.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 454600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 454600000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 65700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 65700000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4992500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4992500000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 17100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 17100000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 45100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 45100000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 583400000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 99100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 99100000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 44600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 17500000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 3560800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 922000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Payable: 57000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 57000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Properties: 10570300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 10570300000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 15800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 15800000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 53500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 53500000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Other Special Charges: -23700000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Payables: 1502900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1502900000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 33300000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 86300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 86300000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Preferred Securities Outside Stock Equity: 1201000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 1201000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Preferred Stock: 1663700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 1663700000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Preferred Stock Dividends: 49000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Preferred Stock Equity: 1663700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 1663700000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Preferred Stock Payments: 0.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 331600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 331600000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Pretax Income: 333900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 40100000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -500000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -205000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 2981700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2981700000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 13408300000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3290400000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 516900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 130500000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 4400000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 4400000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1135700000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 4600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 4600000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2925800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2925800000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 0.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 28000000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 884400000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 930300000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Share Issued: 60499050.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 60499050.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 6777200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6777200000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 5096400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5096400000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Tax Provision: 73800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 900000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.22
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.02
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 168800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 168800000.00
EMAMIPAP.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -75300000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Assets: 18171400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 18171400000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 9921200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9921200000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Debt: 7697000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 7697000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 6777200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6777200000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Total Expenses: 18379200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 4568900000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 11394200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11394200000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 11326600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11326600000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4887800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4887800000.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 40000000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
EMAMIPAP.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Work In Process: 182100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 182100000.00
EMAMIPAP.NS balance_sheet (annual, 2025-03-31) — Working Capital: 338400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 338400000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 860100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4597600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 75119048.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.84
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3489500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 128800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 128800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 77901235.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.81
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — EBIT: 264000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — EBITDA: 392800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1108100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 170500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 170500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Income: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -170500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -170500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 392800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 63100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Operating Income: 248000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4597600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 16000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 500300000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 93500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3489500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 128800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 30400000.00
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.33
EMAMIPAP.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 4349600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1233800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 4506100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2517500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2665900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 41300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 569200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 64509804.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.02
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1206000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 66100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 121000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4735200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 22400000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 3047400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 7480400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 4508800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4509000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 7503500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 44900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 137700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 137700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 73932584.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.89
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — EBIT: 274000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — EBITDA: 411700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 9900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 10541100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1458700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 44600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 173300000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 173300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 4178600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 10639200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 569200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1395200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1397100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 240700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 5903200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Income: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -173300000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -173300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 10541100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5810300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1447900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 411700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 65800000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Operating Income: 224900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 4506100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 60499050.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 411800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 87800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4614200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 9900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 48000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 49100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 862600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 10518700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 3400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 65300000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Payables: 2517500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 2159100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 1085000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 1085000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 100700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 3047400000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 137700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 60499050.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5820200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4725300000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 34900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.35
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 68700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 18649400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7215400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 5906100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5820200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 4281200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 12829200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 11169000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 5325700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: -23100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1262100000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 5004500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 68785425.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 2.47
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 3283500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 141000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 141000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 69065041.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.46
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — EBIT: 441700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — EBITDA: 582700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1721000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 177200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 177200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Income: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 169900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -177200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -177200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 607900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 186087069.94
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Operating Income: 458900000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 5004500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 8000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 876700000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 264500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 3283500000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 141000000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -25200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -9012930.06
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 94600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.36
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 4545600000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -25200000.00
EMAMIPAP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -25200000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4955200000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1257800000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — +Total Revenue: 19072300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4964100000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1963500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1963500000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2736000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2736000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 28200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 28200000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 444000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 444000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 65717345.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 62874251.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Basic EPS: 9.34
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.01
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -296300000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 2100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2100000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 916700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 916700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1400000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 49200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 49200000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -145800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 73800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 400000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Common Stock: 121000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 121000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 4957400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4957400000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 46200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 46200000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 12703100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3224100000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Current Assets: 7361200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 7361200000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 200000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Current Debt: 4139100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 4139100000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 4139300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4139300000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 6632900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6632900000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 49800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 49800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Depreciation: 546900000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 546900000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 546900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 139400000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 546900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 139400000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 70632911.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 69536424.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Diluted EPS: 8.69
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.53
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 315000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 11200000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — EBIT: 1612400000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — EBIT: 632700000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — EBITDA: 2159300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — EBITDA: 772100000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1400000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -1716700000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1676000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2800000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 10327200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 10327200000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Gross Profit: 6369200000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1740000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 133700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 133700000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Interest Expense: 678800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 157800000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 678800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 157800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -525500000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Inventory: 3877900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3877900000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 13128900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 13128900000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -255200000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 24600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 24600000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 444000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 444000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 991700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 1900000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1900000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 4032400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4032400000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4034300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4034300000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 991700000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1327900000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 247000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 247000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Net Debt: 8170100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 8170100000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Income: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Income: 315000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 315000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 315000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 315000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 315000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 933600000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 613800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 315000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Interest Income: -678800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -157800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 28600000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -595200000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -336200000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -678800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -157800000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Net PPE: 10327200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 10327200000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -295000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net Preferred Stock Issuance: -450000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -259000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5750300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5750300000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1495500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1495500000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2171800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 759400000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Normalized Income: 622018187.66
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 306576121.29
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1972300000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Operating Income: 1414000000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Operating Income: 482200000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Operating Revenue: 19072300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 4964100000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 60499050.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 60499050.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 532200000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 532200000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 249700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 249700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 4836400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 4836400000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 2800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 542700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 64400000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 64400000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 210900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 137800000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 3483000000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 902000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Properties: 10281000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 10281000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 4000000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4000000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 47800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 47800000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Payables: 2020800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2020800000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Preferred Stock: 795700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 795700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Preferred Stock Equity: 795700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 795700000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Preferred Stock Payments: -450000000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Pretax Income: 933600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 474900000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -25200000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -296300000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 12703100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3224100000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 546900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 139400000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1327900000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -450000000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 53800000.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1300000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Share Issued: 60499050.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 60499050.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Special Income Charges: -12500000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 12700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5753100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5753100000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 4954600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4954600000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -4281812.34
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 4276121.29
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Tax Provision: 319800000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 159900000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.34
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.34
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 0.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 0.00
EMAMIPAP.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -124700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Assets: 18224800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 18224800000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 9785500000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 9785500000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Debt: 8173600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 8173600000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 5753100000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5753100000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Total Expenses: 17658300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4481900000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 12471700000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 12471700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 10863600000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 10863600000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5838800000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5838800000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 57300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 57300000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -12500000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 12700000.00
EMAMIPAP.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12500000.00
EMAMIPAP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 12700000.00
EMAMIPAP.NS balance_sheet (annual, 2026-03-31) — Working Capital: 728300000.00
EMAMIPAP.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 728300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 966600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 5601600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 62173913.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 6.21
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 3934900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 129300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 129300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 67855888.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 5.69
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — EBIT: 702200000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — EBITDA: 831500000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 1666700000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 169600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 169600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Income: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -169600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -169600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 831500000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 386100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Operating Income: 700100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 5601600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 2100000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 597900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 532600000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 3934900000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 129300000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 146500000.00
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.28
EMAMIPAP.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 4901500000.00
EMAN.L income_statement (annual, 2021-12-31) — +Operating Expense: 38364000.00